Previous studies have reported that overexpression of SIRT1 significantly enhances resistance to cisplatin and paclitaxel in vitro, and overexpression of SIRT1 accelerates the growth of tumor xenografts in nude mice and cisplatin resistance in vivo (Asaka et al. 2015). Here, SIRT1 is linked to neoplasm.